EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of Dopamine Signaling and Neuroinflammation in Age‐Related Cognitive Dysfunction

Junior Bowen, Katie Hanna, Andrew M J Young, Gisela Helfer, Samantha L McLean iD

Brain and Behavior · 2026-04 · 16 (4)

DOI: 10.1002/brb3.71395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 14.04.2026. Verfasst von Junior Bowen und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Optometry and Medical Sciences, University of Bradford, Bradford, UK. Hauptthemen laut MEDLINE: Prefrontal Cortex, Dopamine, Aging, Neuroinflammatory Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PhD tuition fees for J.B. were funded by School of Pharmacy, Optometry and Medical Sciences, University of Bradford.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Age‐related cognitive decline is a growing public health concern, yet early molecular indicators remain poorly defined. Since brain changes often precede behavioral symptoms, identifying early markers of vulnerability is critical. Here, we investigated whether dopamine regulation and synaptic or inflammatory signaling might provide early indicators of cognitive decline, prior to behavioral impairment. Method and Finding : Female hooded‐Lister rats at 6 (young) and 12 (age‐unimpaired) months of age were tested using the novel object recognition (NOR) task, with no observable cognitive deficits found in either group. Biochemical analyses revealed marked molecular differences in the prefrontal cortex (PFC) of aged‐unimpaired rats. Synaptic proteins BDNF, PSD‐95, and synaptophysin were significantly reduced, indicating synaptic destabilization. Concurrently, expression of COMT and NET, key regulators of dopamine catabolism and reuptake, was increased, suggesting reduced dopaminergic tone. Inflammatory signaling also shifted: Nfkb and Socs3 were increased at the transcriptional level in the PFC, while Il‐6 and Cox2 remained stable. In contrast, the hippocampus showed relative resistance to these changes, with no significant alterations in most markers, although NF‐κB activation was detected at the mRNA level, indicating posttranscriptional regulation.

Conclusion

Our findings suggest that the PFC undergoes a latent vulnerability phase during midlife, marked by synaptic and dopaminergic dysregulation alongside low‐grade inflammation, despite preserved cognitive performance. The hippocampus appears more resilient at this stage. Together, these early molecular changes may indicate later cognitive decline and offer a critical window for preventive intervention. Targeting these early shifts in the aging brain could hold transformative potential for delaying cognitive impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prefrontal CortexDopamineAgingNeuroinflammatory DiseasesCognitive DysfunctionAnimalsFemaleRatsSignal TransductionHippocampusBrain-Derived Neurotrophic FactorNF-kappa BRecognition, PsychologyInterleukin-6Catechol O-MethyltransferaseSynaptophysinDisks Large Homolog 4 ProteinInflammation

Stichwörter der Autor:innen

agingbrain‐derived neurotrophic factor (BDNF)dopamine metabolismneuroinflammationprefrontal cortexsynaptic integrity

Substanzen

DopamineBrain-Derived Neurotrophic FactorNF-kappa BInterleukin-6Catechol O-MethyltransferaseSynaptophysinDisks Large Homolog 4 ProteinBdnf protein, rat

Autor:innen und Institutionen

  • School of Pharmacy, Optometry and Medical Sciences, University of Bradford, Bradford, UK.
  • School of Psychology and Vision Sciences, University of Leicester, Leicester, UK.

ORCID-Profile: Samantha L McLean

Förderung

  • PhD tuition fees for J.B. were funded by School of Pharmacy, Optometry and Medical Sciences, University of Bradford

Zitieren

APA

Bowen, J., Hanna, K., Young, A. M. J., Helfer, G., & McLean, S. L. (2026). The Role of Dopamine Signaling and Neuroinflammation in Age‐Related Cognitive Dysfunction. Brain and Behavior, 16(4). https://doi.org/10.1002/brb3.71395

Vancouver

Bowen J, Hanna K, Young AMJ, Helfer G, McLean SL. The Role of Dopamine Signaling and Neuroinflammation in Age‐Related Cognitive Dysfunction. Brain and Behavior. 2026;16(4). doi:10.1002/brb3.71395

BibTeX
@article{Bowen2026,
  author = {Bowen, Junior and Hanna, Katie and Young, Andrew M J and Helfer, Gisela and McLean, Samantha L},
  title = {The Role of Dopamine Signaling and Neuroinflammation in Age‐Related Cognitive Dysfunction},
  journal = {Brain and Behavior},
  year = {2026},
  volume = {16},
  number = {4},
  doi = {10.1002/brb3.71395}
}
Kostenlos starten →